Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 08:41 am Sale |
2024-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 3,330,236 6.710% |
-160,270![]() (-4.59%) |
Filing History |
2025-02-11 09:09 am Purchase |
2024-12-31 | 13G | Bicycle Therapeutics plc BCYC |
WESTFIELD CAPITAL MANAGEMENT CO LLC | 2,610,337 5.490% |
2,610,337![]() (New Position) |
Filing History |
2024-12-20 4:05 pm Purchase |
2024-12-13 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 4,230,302 8.900% |
3,209,134![]() (+314.26%) |
Filing History |
2024-12-19 3:47 pm Purchase |
2024-11-21 | 13G | Bicycle Therapeutics plc BCYC |
Forbion Growth Opportunities Fund II Cooperatief U.A. | 3,452,330 7.300% |
3,452,330![]() (New Position) |
Filing History |
2024-12-17 6:46 pm Purchase |
2024-12-13 | 13D | Bicycle Therapeutics plc BCYC |
Baker Bros. Advisors LP | 10,885,357 22.900% |
1,485,397![]() (+15.80%) |
Filing History |
2024-11-14 5:46 pm Unchanged |
2024-09-30 | 13G | Bicycle Therapeutics plc BCYC |
RA Capital Management, L.P. | 2,253,000 4.700% |
0 (Unchanged) |
Filing History |
2024-11-14 4:32 pm Sale |
2024-09-30 | 13G | Bicycle Therapeutics plc BCYC |
Paradigm BioCapital Advisors LP | 0 0.000% |
-3,707,001![]() (Position Closed) |
Filing History |
2024-11-13 9:30 pm Sale |
2024-09-30 | 13G | Bicycle Therapeutics plc BCYC |
Jefferies Financial Group Inc. JEF |
0 0.000% |
-1,948,000![]() (Position Closed) |
Filing History |
2024-06-07 4:18 pm Purchase |
2024-05-28 | 13G | Bicycle Therapeutics plc BCYC |
RA Capital Management, L.P. | 2,253,000 5.000% |
2,253,000![]() (New Position) |
Filing History |
2024-05-28 4:16 pm Purchase |
2024-05-23 | 13D | Bicycle Therapeutics plc BCYC |
Baker Bros. Advisors LP | 9,399,960 19.900% |
1,710,717![]() (+22.25%) |
Filing History |
2024-04-18 07:29 am Purchase |
2024-04-16 | 13D | Bicycle Therapeutics plc BCYC |
Baker Bros. Advisors LP | 7,689,243 19.900% |
2,865,645![]() (+59.41%) |
Filing History |
2024-02-14 4:08 pm Sale |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 844,235 2.200% |
-1,420,566![]() (-62.72%) |
Filing History |
2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Paradigm BioCapital Advisors LP | 3,707,001 9.800% |
2,096,336![]() (+130.15%) |
Filing History |
2024-02-14 4:07 pm Purchase |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Jefferies Financial Group Inc. JEF |
1,948,000 5.165% |
1,948,000![]() (New Position) |
Filing History |
2024-02-14 08:37 am Purchase |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 3,490,506 9.250% |
671,461![]() (+23.82%) |
Filing History |
2024-02-12 4:10 pm Purchase |
2024-01-31 | 13G | Bicycle Therapeutics plc BCYC |
Baker Bros. Advisors LP | 4,823,598 12.800% |
4,823,598![]() (New Position) |
Filing History |
2024-02-12 11:59 am Sale |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-1,503,447![]() (Position Closed) |
Filing History |
2023-07-19 6:29 pm Unchanged |
2023-07-17 | 13D | Bicycle Therapeutics plc BCYC |
GLAXOSMITHKLINE PLC | 1,529,561 4.400% |
0 (Unchanged) |
Filing History |
2023-02-24 4:54 pm Purchase |
2023-02-14 | 13G | Bicycle Therapeutics plc BCYC |
Paradigm BioCapital Advisors LP | 1,610,665 5.400% |
1,610,665![]() (New Position) |
Filing History |
2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 1,021,168 3.400% |
-551,655![]() (-35.07%) |
Filing History |